By harnessing the most recent development in biology, Synlico Inc. is dedicated to reshape drug discovery from a hit-to-lead approach to a quantitative, design-based engineering process.

In this multi-Omics era, Synlico is using an integrative approach to gain deep insight into different layers of biological elements and identify new therapeutics modalities.

Synlico is on the way to develop a robust pipeline by comprehending the complexity of cancer.

Extraordinary advances need extraordinary people. We need you to bring hope to patients.